-
When drug development companies prepare to enter the clinical phase, they must produce both the Drug Substance (API) and the Drug Product (IMP). Since many organizations lack the in-house capabilities for this, they often turn to Contract Development and Manufacturing Organizations (CDMOs) to handle the production. How can you successfully source these services and select […]